The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Serplulimab Injection Market Research Report 2024
Synopsis
Serplulimab (also known as HLX 10) is a recombinant, humanised, anti-PD1 monoclonal antibody, being developed by Shanghai Henlius Biotech.
Global Serplulimab Injection market is projected to reach US$ 29 million in 2029, increasing from US$ 2 million in 2022, with the CAGR of 45.8% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Serplulimab Injection market research.
Key manufacturers engaged in the Serplulimab Injection industry include Shanghai Henlius Biotech. etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Serplulimab Injection were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Serplulimab Injection market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Serplulimab Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Shanghai Henlius Biotech
Segment by Type
100mg/10ml
Others
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Serplulimab Injection report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Serplulimab (also known as HLX 10) is a recombinant, humanised, anti-PD1 monoclonal antibody, being developed by Shanghai Henlius Biotech.
Global Serplulimab Injection market is projected to reach US$ 29 million in 2029, increasing from US$ 2 million in 2022, with the CAGR of 45.8% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Serplulimab Injection market research.
Key manufacturers engaged in the Serplulimab Injection industry include Shanghai Henlius Biotech. etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Serplulimab Injection were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Serplulimab Injection market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Serplulimab Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Shanghai Henlius Biotech
Segment by Type
100mg/10ml
Others
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Serplulimab Injection report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Serplulimab Injection Market Overview
1.1 Product Overview and Scope of Serplulimab Injection
1.2 Serplulimab Injection Segment by Type
1.2.1 Global Serplulimab Injection Market Value Comparison by Type (2023-2029)
1.2.2 100mg/10ml
1.2.3 Others
1.3 Serplulimab Injection Segment by Application
1.3.1 Global Serplulimab Injection Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Serplulimab Injection Market Size Estimates and Forecasts
1.4.1 Global Serplulimab Injection Revenue 2018-2029
1.4.2 Global Serplulimab Injection Sales 2018-2029
1.4.3 Global Serplulimab Injection Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Serplulimab Injection Market Competition by Manufacturers
2.1 Global Serplulimab Injection Sales Market Share by Manufacturers (2018-2023)
2.2 Global Serplulimab Injection Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Serplulimab Injection Average Price by Manufacturers (2018-2023)
2.4 Global Serplulimab Injection Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Serplulimab Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Serplulimab Injection, Product Type & Application
2.7 Serplulimab Injection Market Competitive Situation and Trends
2.7.1 Serplulimab Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Serplulimab Injection Players Market Share by Revenue
2.7.3 Global Serplulimab Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Serplulimab Injection Retrospective Market Scenario by Region
3.1 Global Serplulimab Injection Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Serplulimab Injection Global Serplulimab Injection Sales by Region: 2018-2029
3.2.1 Global Serplulimab Injection Sales by Region: 2018-2023
3.2.2 Global Serplulimab Injection Sales by Region: 2024-2029
3.3 Global Serplulimab Injection Global Serplulimab Injection Revenue by Region: 2018-2029
3.3.1 Global Serplulimab Injection Revenue by Region: 2018-2023
3.3.2 Global Serplulimab Injection Revenue by Region: 2024-2029
3.4 North America Serplulimab Injection Market Facts & Figures by Country
3.4.1 North America Serplulimab Injection Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Serplulimab Injection Sales by Country (2018-2029)
3.4.3 North America Serplulimab Injection Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Serplulimab Injection Market Facts & Figures by Country
3.5.1 Europe Serplulimab Injection Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Serplulimab Injection Sales by Country (2018-2029)
3.5.3 Europe Serplulimab Injection Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Serplulimab Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Serplulimab Injection Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Serplulimab Injection Sales by Country (2018-2029)
3.6.3 Asia Pacific Serplulimab Injection Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Serplulimab Injection Market Facts & Figures by Country
3.7.1 Latin America Serplulimab Injection Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Serplulimab Injection Sales by Country (2018-2029)
3.7.3 Latin America Serplulimab Injection Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Serplulimab Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Serplulimab Injection Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Serplulimab Injection Sales by Country (2018-2029)
3.8.3 Middle East and Africa Serplulimab Injection Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Serplulimab Injection Sales by Type (2018-2029)
4.1.1 Global Serplulimab Injection Sales by Type (2018-2023)
4.1.2 Global Serplulimab Injection Sales by Type (2024-2029)
4.1.3 Global Serplulimab Injection Sales Market Share by Type (2018-2029)
4.2 Global Serplulimab Injection Revenue by Type (2018-2029)
4.2.1 Global Serplulimab Injection Revenue by Type (2018-2023)
4.2.2 Global Serplulimab Injection Revenue by Type (2024-2029)
4.2.3 Global Serplulimab Injection Revenue Market Share by Type (2018-2029)
4.3 Global Serplulimab Injection Price by Type (2018-2029)
5 Segment by Application
5.1 Global Serplulimab Injection Sales by Application (2018-2029)
5.1.1 Global Serplulimab Injection Sales by Application (2018-2023)
5.1.2 Global Serplulimab Injection Sales by Application (2024-2029)
5.1.3 Global Serplulimab Injection Sales Market Share by Application (2018-2029)
5.2 Global Serplulimab Injection Revenue by Application (2018-2029)
5.2.1 Global Serplulimab Injection Revenue by Application (2018-2023)
5.2.2 Global Serplulimab Injection Revenue by Application (2024-2029)
5.2.3 Global Serplulimab Injection Revenue Market Share by Application (2018-2029)
5.3 Global Serplulimab Injection Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Shanghai Henlius Biotech
6.1.1 Shanghai Henlius Biotech Corporation Information
6.1.2 Shanghai Henlius Biotech Description and Business Overview
6.1.3 Shanghai Henlius Biotech Serplulimab Injection Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Shanghai Henlius Biotech Serplulimab Injection Product Portfolio
6.1.5 Shanghai Henlius Biotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Serplulimab Injection Industry Chain Analysis
7.2 Serplulimab Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Serplulimab Injection Production Mode & Process
7.4 Serplulimab Injection Sales and Marketing
7.4.1 Serplulimab Injection Sales Channels
7.4.2 Serplulimab Injection Distributors
7.5 Serplulimab Injection Customers
8 Serplulimab Injection Market Dynamics
8.1 Serplulimab Injection Industry Trends
8.2 Serplulimab Injection Market Drivers
8.3 Serplulimab Injection Market Challenges
8.4 Serplulimab Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
